BioCentury
ARTICLE | Company News

Genetronics electroporation deal with JNJ

August 28, 2000 7:00 AM UTC

Genetronics (GEB; TSE:GEB) and Johnson & Johnson Research (Eveleigh, Australia), a subsidiary of Johnson & Johnson (JNJ), will conduct in vivo feasibility studies using GEB's electroporation technolog...